Lopez-Ramirez v. Grupo HIMA-San Pablo, Inc.

CourtDistrict Court, D. Puerto Rico
DecidedJanuary 22, 2020
Docket3:16-cv-03192
StatusUnknown

This text of Lopez-Ramirez v. Grupo HIMA-San Pablo, Inc. (Lopez-Ramirez v. Grupo HIMA-San Pablo, Inc.) is published on Counsel Stack Legal Research, covering District Court, D. Puerto Rico primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Lopez-Ramirez v. Grupo HIMA-San Pablo, Inc., (prd 2020).

Opinion

IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF PUERTO RICO

EULALIA LÓPEZ RAMÍREZ, et al.

Plaintiffs

v. CIVIL NO. 16-3192(RAM) GRUPO HIMA SAN PABLO, INC., et al.

Defendants

OPINION AND ORDER

RAÚL M. ARIAS-MARXUACH, District Judge Pending before the Court is codefendant Dr. Maria Toledo- Gonzalez’s Motion in Limine requesting that the Court strike Plaintiffs’ expert witness, Dr. Allan Hausknecht (Dr. Hausknecht). (Docket No. 64). In response, Plaintiffs filed an Opposition to Defendant’s Motion in Limine at Docket No. 64 and codefendant Dr. Maria S. Toledo filed a Reply to Opposition to Motion in Limine. (Docket Nos. 65 and 68, respectively). Having reviewed the parties’ arguments, the case record and the applicable law, the Court hereby GRANTS Dr. Maria Toledo’s Motion in Limine at Docket No. 64. Dr. Allan Hausknecht’s proffered expert opinions regarding the standard of care and Dr. Toledo’s alleged negligence are stricken. I. BACKGROUND On December 23, 2016, Mrs. Eulalia López-Ramírez (“Mrs. López”) and Mrs. Laura Cristina Gaudier-López (“Mrs. Gaudier”) sued Dr. María Toledo-Gonzalez (“Dr. Toledo”) and Centro Médico del Turabo, Inc. d/b/a Hospital HIMA San Pablo Caguas (“HIMA”), amongst other defendants, alleging medical malpractice. (Docket No. 1).1 Specifically, after diagnosing Mrs. López with a facial nerve disorder and right hemifacial spasm, Dr. Toledo performed a right retrosigmoid craniotomy and microvascular decompression

surgery on Mrs. López. (Docket No. 24 ¶¶ 10-17). While Plaintiffs affirm that the operative report indicates that it was a successful operation, they claim that inadequate medical treatment provided by Dr. Toledo, HIMA, and its medical and nursing staff “aggravated [Mrs. López’s] simple facial spasm and caused a cerebral infarction, complete facial paralysis, complete hearing loss, ataxia, vestibular dysfunction, imbalance, taste dysfunction and visual dysfunction.” Id. ¶¶ 18-19; 33. Additionally, Plaintiffs allege that Defendants were negligent because they did not provide Mrs. López with adequate neurological evaluation and treatment during her surgery and stay at HIMA. Id. ¶ 34. Both Dr. Toledo and

HIMA deny that they failed to meet the standard of care. (Docket Nos. 16, 18 and 24).

1 In their original Complaint, Plaintiffs included as defendants Dr. Toledo’s husband and their conjugal partnership, unknown monitoring companies, and unknown insurance companies. (Docket No. 1). Plaintiffs ultimately filed three amended complaints specifying the names of some of said entities and individuals, namely Bromedicon, Next Step Medical Co. Inc., and Gustavo J. Nogales-Pérez. (Docket Nos. 5, 8 and 20-1). Plaintiffs voluntarily dismissed their claims as to Dr. Toledo’s husband, Gustavo J. Nogales-Pérez, and their conjugal partnership because of the prenuptial agreement between them. (Docket No. 31 and 31). Plaintiffs retained Dr. Allan Hausknecht (“Dr. Hausknecht”) as their expert witness and proffered that he would testify as to “his review of the pertinent records, the standards of care applicable to this case, the defendant’s departures from such standards, the causal relationship of these departures with the damages sustained by Mrs. López, the contents of his expert report

and deposition, and the applicable medical literature.” (Docket No. 49 at 37). On September 18, 2019, codefendant Dr. Toledo filed a Motion in Limine (“Motion”) requesting that the court strike Dr. Hausknecht as an expert for three reasons. (Docket No. 64). First, Dr. Toledo contends that Dr. Hausknecht’s expert reports do not include a statement notifying the compensation received for his testimony and thus fail to comply with Fed. R. Civ. P. 26(a)(2)(B). Id. at 10. Second, Dr. Toledo posits that Dr. Hausknecht is not qualified to be an expert in this case because he is not trained in neurosurgery, has never performed the surgery in dispute and

has never overseen interoperative neuromonitoring. Id. at 10-11. Third, Dr. Toledo argues that Dr. Hausknecht’s contention that she was negligent because of Mrs. López’s symptoms after the surgery is an improper res ipsa loquitur opinion. Id. at 11-12. In response, Plaintiffs filed an Opposition to Defendant’s Motion in Limine on October 2, 2019. (Docket No. 65). Plaintiffs argued that failing to include a statement of compensation was a harmless error, especially considering that they produced Dr. Hausknecht’s invoices during discovery. Id. at 8-9. They also affirmed that Dr. Hausknecht, a board certified neurologist, does not need to be a neurosurgeon to provide a relevant and reliable expert opinion. Id. at 10-11. Lastly, although Plaintiffs conceded that the res ipsa loquitur doctrine has been abrogated,

circumstantial evidence is still admissible to prove negligence by Dr. Toledo. Id. at 12-14. On October 10, 2019, Dr. Toledo filed a Reply to Opposition to Motion in Limine. (Docket No. 68). II. LEGAL STANDARD A. The Admissibility of Expert Witness Testimony Federal Rule of Evidence 702 governs the admissibility of expert witness testimony. Specifically, Fed. R. Evid. 702 (“Rule 702”) establishes that: A witness who is qualified as an expert by knowledge, skill, experience, training, or education may testify in the form of an opinion or otherwise if: (a) the expert’s scientific, technical, or other specialized knowledge will help the trier of fact to understand the evidence or to determine a fact in issue; (b) the testimony is based on sufficient facts or data; (c) the testimony is the product of reliable principles and methods; and (d) the expert has reliably applied the principles and methods to the facts of the case.

Pursuant to Rule 702, trial judges are tasked with “ensuring that an expert’s testimony both rests on reliable foundation and is relevant to the task at hand.” Daubert v. Merrell Dow Pharms., Inc., 509 U.S. 579, 597 (1993). When applying this rule, judges must assume the “role of gatekeepers to screen expert testimony that although relevant, was based on unreliable scientific methodologies.” González–Pérez v. Gómez- Águila, 296 F.Supp.2d 110, 113 (D.P.R. 2003) (citing Daubert, 509 U.S. at 597 (1993))

(“Pertinent evidence based on scientifically valid principles will satisfy those demands.”) When assessing the reliability of expert testimony, trial courts can consider the following factors discussed in Daubert: (1) whether the expert’s theory or technique is generally accepted as reliable in the scientific community; (2) whether the theory or technique in question can be, and has been, tested; (3) whether the theory or technique has been subjected to peer review and publication; and (4) the known or potential rate of error of the theory or technique. See Daubert, 509 U.S. at 588-594. In the performance of their gatekeeping function, judges must

focus “solely on principles and methodology, not on the conclusions that they generate.” Id. at 595. Although certainly conclusions and methodology are not entirely distinct from one another, “a court may conclude that there is simply too great an analytical gap between the data and the opinion proffered.” Gen. Elec. Co. v. Joiner, 522 U.S. 136, 146 (1997) (emphasis added). In other words, under Daubert, an expert cannot merely state their qualifications, conclusions and assurances of reliability. See Daubert v. Merrell Dow Pharm., Inc., 43 F.3d 1311, 1319 (9th Cir.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Romero v. Drummond Co., Inc.
552 F.3d 1303 (Eleventh Circuit, 2008)
Daubert v. Merrell Dow Pharmaceuticals, Inc.
509 U.S. 579 (Supreme Court, 1993)
General Electric Co. v. Joiner
522 U.S. 136 (Supreme Court, 1997)
PAGÉS-RAMÍREZ v. Ramirez-Gonzalez
605 F.3d 109 (First Circuit, 2010)
Cruz-Vázquez v. Mennonite General Hospital, Inc.
613 F.3d 54 (First Circuit, 2010)
Rolon-Alvarado v. Municipality of San Juan
1 F.3d 74 (First Circuit, 1993)
Mitchell v. United States
141 F.3d 8 (First Circuit, 1998)
Marcano Rivera v. Turabo Medical Center Partnership
415 F.3d 162 (First Circuit, 2005)
Esposito v. Home Depot U.S.A., Inc.
590 F.3d 72 (First Circuit, 2009)
Brenda Payton v. Abbott Labs, Eli Lilly and Company
780 F.2d 147 (First Circuit, 1985)
Wegener v. Johnson
527 F.3d 687 (Eighth Circuit, 2008)
Strickland v. Pinder
899 A.2d 770 (District of Columbia Court of Appeals, 2006)
Baker v. Chevron USA, Inc.
680 F. Supp. 2d 865 (S.D. Ohio, 2010)
Figueroa v. Simplicity Plan De Puerto Rico
267 F. Supp. 2d 161 (D. Puerto Rico, 2003)
Porter v. McHugh
850 F. Supp. 2d 264 (District of Columbia, 2012)
Carolyn Baker v. Chevron U.S.A. Inc.
533 F. App'x 509 (Sixth Circuit, 2013)

Cite This Page — Counsel Stack

Bluebook (online)
Lopez-Ramirez v. Grupo HIMA-San Pablo, Inc., Counsel Stack Legal Research, https://law.counselstack.com/opinion/lopez-ramirez-v-grupo-hima-san-pablo-inc-prd-2020.